DiaSorin—publicly listed on the FTSE MIB Index since 2007— is an Italy-based company globally operating in laboratory diagnostics. It develops, produces and markets testing devices and equipment that enable doctors worldwide to make accurate diagnosis. Every second, 10 people in the world encounter DiaSorin.